• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Oral Semaglutide: Cardiovascular Outcomes, Safety, and Tolerability

Video

The safety profile of oral semaglutide across the PIONEER trials was shown to be consistent with other glucagon-like peptide-1 receptor agonists (GLP-1RAs).

Click PLAY to watch the video abstract.


Click here to watch the full supplement infographic.


Click here to read full article to this video abstract.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.